Get the Weekly Intelligence Brief — top committee picks every Sunday.

IONS vs LQDA

Ionis Pharmaceuticals, Inc. vs Liquidia Corporation — AI-powered side-by-side comparison
IONS
Ionis Pharmaceuticals, Inc.
43
Reduce
VS
LQDA
Liquidia Corporation
68
Buy
MetricIONSLQDA
AI Score 43 68
Price $55.38 $88.09
P/E Ratio -16.02× 368.26×
ROE -77.9% -154.0%
Revenue Growth YoY
Gross Margin 98.2% 91.8%
Debt / Equity 5.50× 1.70×
Dividend Yield 0.0% 0.0%
RSI (14) 46.6 55.0
Beta 0.4 0.572
Expected Upside

AI Committee View

Current Innellis committee reasoning for IONS versus LQDA.
LQDA leads by 25 points.

LQDA scores 68/100 (Buy) versus IONS at 43/100 (Reduce).

IONS Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -7.5% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 26.2x prices in significant intangible value — Value
  • ROE of only -110.9% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 4.77 adds balance-sheet risk to the value case — Value
LQDA Committee View
67% agreement
6 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • ROE of 46.8% shows genuine earnings power backing the valuation — Value
  • Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • P/E of 362.9 is expensive by classic value standards — Value
  • Price-to-book of 12.9x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
IONS Full Analysis LQDA Full Analysis